Sonora Investment Management’s Procept Biorobotics PRCT Stock Holding History

Sonora Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4K	Buy	+100	New	+$3.84K	﹤0.01%	911

Other funds holding PRCT

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Sonora Investment Management's PRCT Position: Q3 2021 in Review

Sonora Investment Management opened a new position in Procept Biorobotics (PRCT) in Q3 2021: 100 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #911 among its holdings.

58 funds tracked by Wall St. Rank hold PRCT as of Q3 2021.

Sonora Investment Management held 100 shares of Procept Biorobotics worth $4K as of Q3 2021.
Procept Biorobotics was a new Sonora Investment Management position in Q3 2021.
Procept Biorobotics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #911 holding.
58 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.